AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Amgen to Invest Over $500M in New R&D Center in California, Creating Hundreds of Jobs.
ByAinvest
Tuesday, Sep 2, 2025 5:37 pm ET1min read
Amgen plans to invest over $500M to build a new R&D center at its Thousand Oaks, California headquarters. The center is expected to create hundreds of jobs in the US.
Amgen (NASDAQ: AMGN) has announced plans to invest over $500 million to build a new science and innovation center at its headquarters in Thousand Oaks, California. This significant investment aims to enhance the company's research and development capabilities and is expected to create hundreds of jobs in the U.S. [1]The expansion of Amgen's headquarters in Thousand Oaks, California, is part of the company's broader strategy to bolster its research and development efforts. The new R&D center is anticipated to be a significant addition to Amgen's existing facilities, which are already a hub for innovative biopharmaceutical research. [2]
According to the company, the new center will be a state-of-the-art facility equipped with the latest technologies and infrastructure necessary for cutting-edge research. The investment is part of Amgen's ongoing commitment to advancing medical science and developing new treatments for various diseases.
This announcement comes at a time when the biotechnology industry is experiencing significant growth and investment. The total US manufacturing pledge by the industry is nearing $300 billion, with Amgen's contribution being a substantial part of this figure. [2]
The creation of hundreds of new jobs at Amgen's Thousand Oaks headquarters is expected to have a positive impact on the local economy. It will not only provide employment opportunities but also contribute to the growth and development of the region.
Amgen's focus on innovation and research is a key factor in its success as a biopharmaceutical company. The new R&D center is anticipated to further strengthen Amgen's position in the industry by enabling it to develop more effective and efficient treatments.
References:
[1] https://seekingalpha.com/news/4491236-amgen-build-new-rd-center-in-california
[2] https://endpoints.news/amgen-to-expand-california-headquarters-with-new-600m-rd-center/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet